|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.391 SEK | +30.33% |
|
+22.57% | -15.37% |
Klaria Pharma Holding AB (publ.) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was SEK 6.17 million compared to SEK 2.02 million a year ago. Net loss was SEK 39.09 million compared to SEK 16.99 million a year ago.
Basic loss per share from continuing operations was SEK 0.75 compared to SEK 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.37% | 3.84M | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
KLARIA PHARMA HOLDING AB 